LegalZoom.com's stock rating was upgraded from "hold" to "buy" by Wall Street Zen analysts, although other analysts hold mixed views with an average "Hold" rating and a consensus price target of $8.25. The company's shares rose 0.6% to $7.25, trading above its 12-month low despite recent insider share sales. LegalZoom recorded $206.78 million in revenue, surpassing expectations, but missed EPS estimates by $0.01 in its latest quarter.

Vipshop (NYSE:VIPS) was downgraded from a "buy" to a "hold" rating by Wall Street Zen, contributing to a mixed outlook from analysts. Despite other firms having varied ratings, the consensus remains a "Moderate Buy" with an average target price of $20.20. The stock recently traded up 0.8% at $13.97, and institutional investors have been actively trading shares, with 48.82% of the stock owned by hedge funds and other institutional investors.

International Assets Investment Management LLC increased its stake in International Business Machines Corporation by 32.2% during the first quarter, adding 3,641 shares to own a total of 14,947 shares valued at $3,634,000. Other institutional investors also adjusted their positions in IBM. The article also provides details on IBM's recent stock performance, financial metrics, increased dividend, and analyst ratings, alongside key news impacting the company, particularly its advancements in quantum computing and AI.

Morgan Stanley identifies China's rapidly advancing reusable rocket program as the biggest long-term competitive threat to SpaceX, following China's successful recovery of an orbital-class rocket booster. While Beijing still needs to demonstrate repeated launches, this achievement significantly closes the gap. Despite this, Morgan Stanley maintains an "overweight" rating on SpaceX, acknowledging its continued leadership in launch cadence and satellite connectivity.

LGT Fund Management Co Ltd. significantly increased its holdings in Fortinet, Inc. (NASDAQ:FTNT) by 102.3% in the first quarter, now owning 89,819 shares valued at $7.34 million. This comes after Fortinet reported strong financial results with $0.82 EPS and $1.85 billion in revenue, exceeding expectations. Despite insider selling and a cautious "Hold" rating from analysts, institutional investors are actively adjusting their positions in the cybersecurity firm.

S&P Global has downgraded Oracle's credit rating from BBB to BBB- due to extreme customer concentration risk stemming from OpenAI, which accounts for approximately half of Oracle's $638 billion in remaining performance obligations. The downgrade is also driven by Oracle's ballooning AI infrastructure buildout, projected to widen its free cash flow deficit to negative $42 billion. Oracle's shares are down 28% year-to-date and the company plans to raise $20 billion in additional equity to preserve its investment-grade status.

Associated Banc-Corp (ASB) has appointed Andy Miner as senior director, AI for Corporate & Commercial Banking. Despite a recent strong stock performance, ASB is currently trading below its widely followed fair value estimate of $32.33, indicating it might be undervalued. However, the article highlights potential risks such as higher credit losses from commercial and CRE exposure or underperforming deposit growth.

Wall Street Zen downgraded Absci (NASDAQ:ABSI) from a "hold" to a "sell" rating, despite several other analysts recently raising their price targets and maintaining "buy" ratings, leading to an overall "Moderate Buy" consensus. The downgrade followed Absci's quarterly results, which showed a narrower-than-expected loss but significantly missed revenue expectations. Despite the mixed analyst outlook, institutional investors have been actively adjusting their positions in the stock.

Brian E. Harding, Chief Accounting Officer of Ultra Clean Holdings (UCTT), sold 3,837 shares of common stock for approximately $494,000 on July 2, 2026, through a pre-planned Rule 10b5-1 trading plan. This sale reduced his direct holdings by 10%, but he still retains a significant stake. The transaction occurred as the stock began a slide from the selling price of $128.75, which highlights the strategic nature of the pre-set plan.

Charles River Laboratories International (CRL) has expanded its AI-enabled digital pathology platform, coinciding with the stock reaching a 52-week high and attracting investor attention. While a popular narrative suggests the company is 25.6% undervalued with a fair value of $313.61, Simply Wall St's DCF model indicates the stock is overvalued at a future cash flow value of $115.19. Investors are encouraged to review both perspectives to assess the company's valuation.